Transfection Technologies Market Report 2026

Transfection Technologies Market Overview

• Transfection Technologies market size has reached to $1.31 billion in 2025 • Expected to grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Growth In Gene Therapy Fuels Expansion Of The Transfection Technologies Market • Market Trend: Advancements In Mechanoporation Technology For Enhanced Cell Transfection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transfection Technologies Market?

Transfection technologies are the intentional introduction of nucleic acids into cells using chemical, physical, or biological methods to modify gene expression or genetic content. It is used to study gene function, produce proteins, silence genes via ribonucleic acid(RNA) interference (siRNA/miRNA), and potentially treat genetic diseases by introducing functional genes. The main types of transfection technology products are kits and reagents, equipment, and others. Kits and reagents for transfection technologies provide ready-to-use solutions that streamline the introduction of nucleic acids into cells for applications such as gene expression and genome editing. It is performed by various transfection methods such as lipofection, electroporation, nucleofection, cotransfection, cationic lipid transfection, in-vivo transfection, and others for several applications, including virus production, protein production, gene silencing, stem cell reprogramming and differentiation, stable cell line generation, therapeutic delivery, biomedical research, and others. It is used by various end-users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), academic and research institutes, and others.

What Is The Transfection Technologies Market Growth Forecast?

The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growth of cell and gene therapies, increasing rna therapeutics pipelines, rising investment in life sciences research, demand for efficient transfection reagents, expansion of personalized medicine. Major trends in the forecast period include rising demand for gene editing research tools, expansion of rna-based therapeutics development, increasing use in cell and gene therapy, growth in academic and biomedical research, advancement in non-viral transfection methods.

Global Transfection Technologies Market Segmentation

1) By Product: Kits And Reagents, Equipment, Other Products 2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods 3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users Subsegments: 1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents 2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment 3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Is The Driver Of The Transfection Technologies Market?

The rise in gene therapy is expected to propel the growth of the transfection technologies market going forward. Gene therapy is a technique that aims to treat or prevent diseases by modifying genes, which includes inserting, repairing, or replacing faulty genes. Gene therapy's rise is driven by progress in genetic research, enhanced delivery methods, and its ability to treat previously incurable genetic conditions. Transfection technologies are crucial for gene therapy, facilitating the precise, safe, and effective delivery of genetic material into cells. They support both temporary and permanent genome modifications, essential for treating genetic diseases and cancers. For instance, in December 2024, according to American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the transfection technologies industry.

Key Players In The Global Transfection Technologies Market

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Global Transfection Technologies Market Trends and Insights

Major companies in the transfection technologies market are focused on developing advanced technology, such as mechanoporation transfection systems, to enable more complex and personalized applications in research and therapeutics. Mechanoporation transfection systems use mechanical forces to create temporary pores in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, preserving better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Using controlled, rapid deformation in microfluidic channels, CellPore efficiently introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These features are critical for advancing research and the development of cutting-edge cell and gene therapies.

What Are Latest Mergers And Acquisitions In The Transfection Technologies Market?

In July 2023, Sartorius Stedim Biotec, a France-based company that provides biopharmaceutical and life science research solutions, acquired Polyplus for an undisclosed amount. The acquisition aims to enhance Sartorius's biopharmaceutical offerings by incorporating innovative cell and gene therapy technologies. The deal broadens Sartorius' portfolio with critical components such as transfection reagents, plasmid design, and protein manufacturing. Polyplus is a France-based manufacturer of transfection reagents.

Regional Insights

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Transfection Technologies Market?

The transfection technologies market consists of revenues earned by entities by providing services such as gene expression analysis, gene editing and therapy, and cell line development. The market value includes the value of related goods sold by the service provider or included within the service offering. The transfection technologies market also includes sales of transfection buffers, viral vectors, cell sorting and detection tools, and nanoparticles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transfection Technologies Market Report 2026?

The transfection technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transfection technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.